At a glance
- Originator Wyeth
- Class Benzodiazepines
- Mechanism of Action Vasopressin V2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes insipidus; Genitourinary disorders
Most Recent Events
- 06 Aug 2003 No development reported - Preclinical for Diabetes insipidus in USA (PO)
- 06 Aug 2003 No development reported - Preclinical for Genitourinary disorders in USA (PO)
- 27 Mar 2002 American Home Products and its subsidiaries Wyeth-Ayerst and Wyeth Lederle are both now called Wyeth